Kirk Randal J, et al. – ‘SC 13D/A’ on 1/8/01 re: Clinical Data Inc

On:  Monday, 1/8/01, at 3:31pm ET   ·   Accession #:  916641-1-20   ·   File #:  5-39041

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Amendment to General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment 3 to Schedule 13D                            9     35K 
 2: EX-7        Joint Filing Agreement                                 1      6K 

SC 13D/A   —   Amendment 3 to Schedule 13D
Document Table of Contents

SC 13D/A
1st Page of 9
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION  
Washington, D.C. 20549  

SCHEDULE 13D  
Under the Securities Exchange Act of 1934 
(Amendment No. 3) 

NOVITRON INTERNATIONAL, INC.  
----------------------------  
(Name of Issuer)  

COMMON STOCK, $.01 par value per share  
--------------------------------------  
(Title of Class of Securities)  

670088103 
--------- 
(CUSIP Number)  

Third Security, LLC 
The Governor Tyler  
1902 Downey Street  
Radford, Virginia 24141 
Attention: Marcus E. Smith, Esq.  
Telephone No.: 540-633-7971 
--------------------------- 
(Name, Address and Telephone Number of Person Authorized to Receive Notices and 
Communications) 

Copy to:  
John Owen Gwathmey, Esq.  
Hunton & Williams 
Riverfront Plaza, East Tower  
951 East Byrd Street  
Richmond, Virginia 23219  

December 31, 2000 
----------------- 
(Date of Event which Requires Filing of This Statement) 

If the filing person has previously filed a statement   
on Schedule 13G to report the acquisition which is the  
subject of this Schedule 13D, and is filing this  
schedule because of Rules 13d-1(e), (f) or (g), 
check the following box [_].  

Page 1 of 10 Pages  

SC 13D/A
2nd Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 2nd
--------------------------                            ------------------------  
CUSIP NO. 670088103                  13D               Page 2 of 10 Pages       
--------------------------                            ------------------------  

------------------------------------------------------------------------------  
1    NAMES OF REPORTING PERSONS                                               
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).        

Randal J, Kirk                                                      
------------------------------------------------------------------------------  
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                         
                                                       (a) [_]
                                                       (b) [X]
------------------------------------------------------------------------------  
3    SEC USE ONLY                                                             

------------------------------------------------------------------------------  
4    SOURCE OF FUNDS                                                          

PF                                                                  
------------------------------------------------------------------------------  
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT        
TO ITEM 2(d) or 2(e)                                          [_]   

------------------------------------------------------------------------------  
6    CITIZENSHIP OR PLACE OF ORGANIZATION                                     

United States                                                       
------------------------------------------------------------------------------  
7    SOLE VOTING POWER                

NUMBER OF                                                             
302,232                     
    SHARES       -----------------------------------------------------------
8    SHARED VOTING POWER              
BENEFICIALLY                                                              

OWNED BY             99,801                                           
                 -----------------------------------------------------------
EACH          9    SOLE DISPOSITIVE POWER                         

REPORTING                                                               
302,232                     
    PERSON       -----------------------------------------------------------
10   SHARED DISPOSITIVE POWER         
WITH                                                              
99,801                      
------------------------------------------------------------------------------  
11    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON              

402,033                                                             
------------------------------------------------------------------------------  
12    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     

                                                           [_]
------------------------------------------------------------------------------  
13    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                        

27.8%                                                               
------------------------------------------------------------------------------  
14    TYPE OF REPORTING PERSON                                                  

IN                                                                  
------------------------------------------------------------------------------  

SC 13D/A
3rd Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 3rd
--------------------------                            ------------------------  
CUSIP NO. 670088103                  13D               Page 3 of 10 Pages       
--------------------------                            ------------------------  

------------------------------------------------------------------------------  
1    NAMES OF REPORTING PERSONS                                               
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).        

    Clinical Chemistry Holdings, Inc.   I.R.S. Identification No.:52-2202556
------------------------------------------------------------------------------  
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                         
                                                       (a) [_]
                                                       (b) [X]
------------------------------------------------------------------------------  
3    SEC USE ONLY                                                             

------------------------------------------------------------------------------  
4    SOURCE OF FUNDS                                                          

WC                                                                  
------------------------------------------------------------------------------  
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT        
TO ITEM 2(d) or 2(e)                                          [_]   

------------------------------------------------------------------------------  
6    CITIZENSHIP OR PLACE OF ORGANIZATION                                     

Delaware                                                            
------------------------------------------------------------------------------  
7    SOLE VOTING POWER                

NUMBER OF                                                             
0                           
    SHARES       -----------------------------------------------------------
8    SHARED VOTING POWER              
BENEFICIALLY                                                              

OWNED BY             0                                                
                 -----------------------------------------------------------
EACH          9    SOLE DISPOSITIVE POWER                         

REPORTING                                                               
0                           
    PERSON       -----------------------------------------------------------
10   SHARED DISPOSITIVE POWER         
WITH                                                              
0                           
------------------------------------------------------------------------------  
11    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON              

0                                                                   
------------------------------------------------------------------------------  
12    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUEDS CERTAIN SHARES     

                                                           [_]
------------------------------------------------------------------------------  
13    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                        

0%                                                                  
------------------------------------------------------------------------------  
14    TYPE OF REPORTING PERSON                                                  

CO                                                                  
------------------------------------------------------------------------------  

SC 13D/A
4th Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 4th
--------------------------                            ------------------------  
CUSIP NO. 670088103                  13D               Page 4 of 10 Pages       
--------------------------                            ------------------------  

------------------------------------------------------------------------------  
1    NAMES OF REPORTING PERSONS                                               
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).        

RJK, L.L.C.                    I.R.S. Identification No.: 54-1816015
------------------------------------------------------------------------------  
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                         
                                                       (a) [_]
                                                       (b) [X]
------------------------------------------------------------------------------  
3    SEC USE ONLY                                                             

------------------------------------------------------------------------------  
4    SOURCE OF FUNDS                                                          

WC                                                                  
------------------------------------------------------------------------------  
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT        
TO ITEM 2(d) or 2(e)                                          [_]   

------------------------------------------------------------------------------  
6    CITIZENSHIP OR PLACE OF ORGANIZATION                                     

Virginia                                                            
------------------------------------------------------------------------------  
7    SOLE VOTING POWER                

NUMBER OF                                                             
0                           
    SHARES       -----------------------------------------------------------
8    SHARED VOTING POWER              
BENEFICIALLY                                                              

OWNED BY             99,801                                           
                 -----------------------------------------------------------
EACH          9    SOLE DISPOSITIVE POWER                         

REPORTING                                                               
0                           
    PERSON       -----------------------------------------------------------
10   SHARED DISPOSITIVE POWER         
WITH                                                              
99,801                      
------------------------------------------------------------------------------  
11    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON              

99,801                                                              
------------------------------------------------------------------------------  
12    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     

                                                           [_]
------------------------------------------------------------------------------  
13    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)                        

6.9%                                                                
------------------------------------------------------------------------------  
14    TYPE OF REPORTING PERSON                                                  

OO - limited liability company                                      
------------------------------------------------------------------------------  

SC 13D/A
5th Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 5th
     This Amendment No. 3 (the "Amendment") amends and supplements the Statement
on Schedule 13D, dated November 26, 1999 and filed on December 6, 1999, as      
amended by Amendment No. 1 dated March 10, 2000 and filed on March 15, 2000 and 
Amendment No. 2 dated June 8, 2000 and filed on June 9, 2000 (the "Original     
Schedule 13D"), relating to the Common Stock, par value $.01 per share (the     
"Common Stock"), of Novitron International, Inc., a Delaware corporation (the   
"Issuer").  Mr. Randal J. Kirk ("Mr. Kirk"), Clinical Chemistry Holdings, Inc., 
a Delaware corporation that is controlled by Mr. Kirk ("CCH"), and RJK, L.L.C., 
a Virginia limited liability company that is controlled by Mr. Kirk ("RJK" and, 
together with Mr. Kirk and CCH, the "Reporting Persons"), are filing this       
Amendment to update the information in the Original Schedule 13D with respect to
the beneficial ownership of the Common Stock by the Reporting Persons.  As      
described in this Amendment, some of the Common Stock that is beneficially owned
by Mr. Kirk is directly beneficially owned by one of the following entities,    
each of which is controlled by Mr. Kirk: Kirkfield, L.L.C., a Virginia limited  
liability company, and Zhong Mei, L.L.C., a Virginia limited liability company. 

Item 2.   Identity and Background                                               
-----------------------                                     

Items 2(a)-(c) of the Original Schedule 13D are amended to read in their  
entirety as follows:                                                            

        "This statement is being filed on behalf of Mr. Randal J. Kirk ("Mr.
Kirk"), Clinical Chemistry Holdings, Inc., a Delaware corporation that is       
controlled by Mr. Kirk ("CCH"), and RJK, L.L.C., a Virginia limited liability   
company that is controlled by Mr. Kirk ("RJK" and, together with Mr. Kirk, the  
"Reporting Persons"). The principal occupation/employment of Mr. Kirk is        
investor. The business address of Mr. Kirk is c/o Third Security, LLC, The      
Governor Tyler, 1902 Downey Street, Radford, Virginia 24141. CCH is a holding   
company for a variety of clinical chemistry-related businesses, including its   
wholly-owned subsidiaries Landmark Scientific, Inc. and Landmark Export         
Corporation. The address of CCH's principal business and office is 101-B        
Creekridge Road, Greensboro, North Carolina 27406. The name, address and present
principal occupation of each of the directors and executive officers of CCH are 
set forth in Appendix A attached hereto. The principal business of RJK is       
investment. The address of RJK's principal business and office is The Governor  
Tyler, 1902 Downey Street, Radford, Virginia 24141. Mr. Kirk is the sole manager
of RJK."                                                                        

Item 3.   Source and Amount of Funds or Other Consideration.                    
--------------------------------------------------          

Item 3 of the Original Schedule 13D is hereby amended and supplemented as 
follows:                                                                        

         "On November 28, 2000, Kirkfield used approximately $1,032 of working
capital to purchase 500 shares of Common Stock.  On December 4, 2000, Kirkfield 
used approximately $408 of working capital to purchase 200 shares of Common     
Stock.  On December 8, 2000, Kirkfield used approximately $416 of working       
capital to purchase 200 shares of Common Stock.  On December 31, 2000, CCH sold 
all 398,133 shares of Common Stock directly beneficially owned by it as follows:
239,269 shares to Mr. Kirk for $690,734; 49,780 shares to Kirkfield for         

Page 5 of 10 Pages  

SC 13D/A
6th Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 6th
$143,707; 99,801 shares to RJK for $288,110; and 9,283 shares to Zhong Mei,     
L.L.C., a Virginia limited liability company controlled by Mr. Kirk ("Zhong     
Mei"), for $26,799."                                                            

Item 5.   Interest in Securities of the Issuer.                                 
-------------------------------------                       

 Item 5(a) of the Original Schedule 13D is hereby amended to read in its
entirety as follows:                                                            

     "The aggregate number and percentage of shares of Common Stock to
which this statement relates is 402,033 shares, representing 27.8% of the       
1,445,227 shares outstanding as reported by the Issuer on November 13, 2000 in  
the Issuer's Quarterly Report on Form 10-Q for the quarter ended September 30,  
2000 (the most recent available filing by the Issuer with the Securities and    
Exchange Commission). Mr. Kirk directly beneficially owns 239,269 of the shares 
to which this statement relates. Kirkfield, RJK and Zhong Mei directly          
beneficially own 53,680, 99,801 and 9,283 shares, respectively, to which this   
statement relates. Mr. Kirk could be deemed to have indirect beneficial         
ownership of the shares directly beneficially owned by Kirkfield, RJK and Zhong 
Mei."                                                                           

 Item 5(b) of the Original Schedule 13D is hereby amended to read in its
entirety as follows:                                                            

        "Mr. Kirk has the sole power to vote or direct the vote and the sole
power to dispose or to direct the disposition of the shares of Common Stock     
reported as directly beneficially owned by him in Item 5(a) hereof and the      
shares of Common Stock reported as being directly beneficially owned by         
Kirkfield and Zhong Mei in Item 5(a) hereof. Mr. Kirk has, together with RJK,   
the shared power to vote or direct the vote and the shared power to dispose or  
to direct the disposition of shares of Common Stock reported as directly        
beneficially owned by RJK in Item 5(a) hereof."                                 

   Item 5(c) of the Original Schedule 13D is hereby amended and supplemented
as follows:                                                                     

         "The following table lists all transactions in shares of Common Stock
by the Reporting Persons that were effected during the period from June 9, 2000,
the date on which Amendment No. 2 to this statement was originally filed with   
the Securities and Exchange Commission, through January 7, 2001. Unless         
otherwise indicated, all such transactions were effected on The Nasdaq SmallCap 
Market.                                                                         

                                                        [Enlarge/Download Table]

                                                 Shares Purchased              Average Price     
Reporting Person                 Date                 (Sold)                    Per Share*       
-------------------------------------------------------------------------------------------------
                                                                                                 
Mr. Kirk (Kirkfield)             11/28/00                   500                    $1.98         
Mr. Kirk (Kirkfield)              12/4/00                   200                    $1.94         
Mr. Kirk (Kirkfield)              12/8/00                   200                    $1.98         
CCH                              12/31/00              (398,133)**                 $2.89         
Mr. Kirk                         12/31/00               239,269**                  $2.89         
Mr. Kirk (Kirkfield)             12/31/00                49,780**                  $2.89         

Page 6 of 10 pages  

SC 13D/A
7th Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 7th
                                                        [Enlarge/Download Table]

                                                 Shares Purchased              Average Price     
Reporting Person                 Date                 (Sold)                    Per Share        
-------------------------------------------------------------------------------------------------
                                                                                                 
 RJK                           12/31/00                 99,801**                    $2.89        
 Mr. Kirk (Zhong Mei)          12/31/00                  9,283**                    $2.89        

*       Price excludes commission.                                              

**      CCH sold 398,133 shares to Mr. Kirk (239,269 shares), Kirkfield (49,780 
shares), RJK (99,801 shares) and Zhong Mei (9,283 shares).      

       Item 5(e) of the Original Schedule 13D is hereby amended to read in its
entirety as follows:                                                            

       "CCH ceased to be the beneficial owner of more than five percent of the
shares of Common Stock on December 31, 2000."                                   

Item 7  Material to be Filed as Exhibits.                                       
---------------------------------                               

       The following document is being filed as an exhibit to this Amendment and
is incorporated herein by reference:                                            

Exhibit 7.  Joint Filing Agreement.                               

Page 7 of 10 Pages  

SC 13D/A
8th Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 8th
SIGNATURE 
--------- 

     After reasonable inquiry and to the best of their knowledge and belief, the
undersigned certify that the information set forth in this statement is true,   
complete and correct.                                                           

Date:  January 8, 2001        /s/ Randal J. Kirk                                
                      ------------------------------------------
Randal J. Kirk      

Date:  January 8, 2001        CLINICAL CHEMISTRY HOLDINGS, INC.                 

        By:  /s/ Audrey Ho Ping Ting
                           -------------------------------------
         Audrey Ho Ping Ting
                           President and Chief Executive Officer

Date:  January 8, 2001        RJK, L.L.C.                                       

   By:  /s/ Randal J. Kirk
                           -------------------------------------
    Randal J. Kirk
Manager   

Page 8 of 10 Pages

SC 13D/A
Last Page of 9
TOC
1st
Previous
Next
↓Bottom
Just 9th
EXHIBIT INDEX 
------------- 

Exhibit Number      Exhibit                                                     
--------------      -------                                                     

Exhibit 7.          Joint Filing Agreement.                                     

Page 9 of 10 Pages  

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘SC 13D/A’ Filing		Date		First		Last			Other Filings
Filed on:		1/8/01		8					4
		1/7/01		6
		12/31/00		1		7			10QSB
		12/8/00		5					4
		12/4/00		5
		11/28/00		5
		11/13/00		6					10QSB
		9/30/00		6					10QSB
		6/9/00		5		6			4,  5,  SC 13D/A
		6/8/00		5
		3/15/00		5					SC 13D/A
		3/10/00		5					4
		12/6/99		5					3,  SC 13D
		11/26/99		5					3
									List all Filings